Alexey M. Kopylov
Moscow, MOW 119991, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Aptamers Structure Flexibility Is Crucial to EGFR Inhibition Function.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 17, 2026
Research of interaction of fluorescent anti-CD133 DNA aptamers with glioblastoma cell cultures using flow cytometry
Journal: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
Published: April 03, 2026
Aptamer-based conjugated molecules in experimental and clinical approaches to treatment of glioblastoma
Journal: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
Published: January 13, 2026
The GQIcombi cocktail attenuates glioblastoma growth in vivo using the rat glioblastoma 101/8 model.
The GQIcombi cocktail attenuates glioblastoma growth in vivo using the rat glioblastoma 101/8 model.
Journal: Biochemical and biophysical research communications
Published: October 20, 2025
The Aptamer bi-(AID-1-T) Synergizes with Radiation to Inhibit Proliferation of Human Glioma Cells.
Journal: Pharmaceutics
Published: October 03, 2025
A PET-CT study of the uptake of labeled aptamers [18F]FB-Gol1 and [18F]FB-GR20 in rat 101.8 glioblastoma model.
Journal: Frontiers in oncology
Published: September 25, 2025
Real-Time Kinetics of Internalization of Anti-EGFR DNA Aptamers and Aptamer Constructs into Cells Derived from Glioblastoma Patients as Indicated by Doxorubicin.
Journal: International journal of molecular sciences
Published: July 21, 2025
Post-Selection Design of Aptamers: Comparative Study of Affinity of the DNA Aptamers to Recombinant Extracellular Domain of Human Epidermal Growth Factor Receptors.
Journal: Biochemistry. Biokhimiia
Published: January 26, 2025
Corrigendum to "Varieties of Interactions of anti-CD133 Aptamers with Cell Cultures from Patient Glioblastoma" [SLAS Discov. 2024 Nov 16;29(8):100195].
Journal: SLAS discovery : advancing life sciences R & D
Published: December 06, 2024
In Silico Born Designed Anti-EGFR Aptamer Gol1 Has Anti-Proliferative Potential for Patient Glioblastoma Cells.
Journal: International journal of molecular sciences
Published: November 15, 2024
Unite and Conquer: Association of Two G-Quadruplex Aptamers Provides Antiproliferative and Antimigration Activity for Cells from High-Grade Glioma Patients.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 21, 2024
Last Updated: 09/26/2026